🔎 Trials Near Me

Home › Wilms Tumor

Wilms Tumor clinical trials recruiting in the U.S.

17 studies for Wilms Tumor are recruiting participants at sites across the United States.

Wilms' Tumor (or Nephroblastoma) is a rare type of cancer that affects one or both kidneys. Find a list of symptoms and treatments associated

Cities with the most studies

By state

Recently updated studies

Biomarkers of Resiliency In Childhood Cancer Surgery

RecruitingObservational study
Ages 3 to 25 · All sexes · Updated Sep 14, 2026 · NCT06674811

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

RecruitingPhase 2
Up to age 30 · All sexes · Updated Aug 25, 2026 · NCT04322318

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

RecruitingPhase 1/2
12 Months – 30 Years · All sexes · Updated Aug 25, 2026 · NCT04851119

Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)

RecruitingPhase 1
Ages 1 to 23 · All sexes · Updated Aug 13, 2026 · NCT07172958

Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

RecruitingPhase 1
Ages 1 to 21 · All sexes · Updated Aug 6, 2026 · NCT04715191

Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors

RecruitingPhase 1/2
6 Months – 25 Years · All sexes · Updated Jun 30, 2026 · NCT06625190

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

RecruitingPhase 1/2
12 Months – 30 Years · All sexes · Updated May 19, 2026 · NCT04901702

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

RecruitingPhase 1
Up to age 21 · All sexes · Updated May 19, 2026 · NCT04897321

A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors

RecruitingPhase 2
12 Months · All sexes · Updated May 6, 2026 · NCT05985161

Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies

RecruitingPhase 1
Ages 1 to 30 · All sexes · Updated Apr 15, 2026 · NCT04308330

Pencil Beam Scanning in Patients With Renal Tumors

RecruitingEarly phase 1
Ages 0 to 30 · All sexes · Updated Apr 15, 2026 · NCT03810651

Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells

RecruitingPhase 1
Up to age 21 · All sexes · Updated Nov 3, 2025 · NCT06198296

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

RecruitingPhase 2
18 Months – 40 Years · All sexes · Updated Aug 12, 2025 · NCT05135975

International PPB/DICER1 Registry

RecruitingObservational studyHealthy volunteers welcome
0 Minutes – 100 Years · All sexes · Updated Jan 30, 2025 · NCT03382158

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.